On the cautious side, there are bound to be more safety trials in librela coming out now - it’sa relatively new drug, and has enjoyed a honeymoon phase without many adverse event studies. But I agree it is a concern - our physio had flagged new research suggesting librela may not be beneficial for certain OA presentations and we’ve come off it with vet support as it didn’t feel like it was showing any benefit, but that might not suit everyone.I haven't read this in full but it's a bit worrying![]()